Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Interest Expenses (2019 - 2025)

Historic Interest Expenses for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to -$6.9 million.

  • CureVac's Interest Expenses fell 436863.65% to -$6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.6 million, marking a year-over-year decrease of 30742.73%. This contributed to the annual value of $885865.6 for FY2024, which is 6697.39% down from last year.
  • As of Q3 2025, CureVac's Interest Expenses stood at -$6.9 million, which was down 436863.65% from -$639557.2 recorded in Q2 2025.
  • In the past 5 years, CureVac's Interest Expenses registered a high of $9.7 billion during Q2 2021, and its lowest value of -$9.5 billion during Q3 2021.
  • Over the past 5 years, CureVac's median Interest Expenses value was -$369363.1 (recorded in 2024), while the average stood at $10.7 million.
  • In the last 5 years, CureVac's Interest Expenses crashed by 21428427406.65% in 2021 and then soared by 43080.9% in 2023.
  • CureVac's Interest Expenses (Quarter) stood at $23.3 million in 2021, then plummeted by 97.24% to $642755.8 in 2022, then skyrocketed by 430.81% to $3.4 million in 2023, then crashed by 54.12% to $1.6 million in 2024, then tumbled by 542.01% to -$6.9 million in 2025.
  • Its Interest Expenses was -$6.9 million in Q3 2025, compared to -$639557.2 in Q2 2025 and $350277.5 in Q1 2025.